During a recent investor survey, Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. stated that it is deepening its collaboration with core strategic partners while reinforcing its existing business foundation. The company has established long-term, stable relationships with several major global pharmaceutical firms, consistently supplying mature commercial projects and annually taking on numerous innovative drug programs at various development stages.

In the domestic market, Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. continues to provide CDMO services to multiple leading innovative drug companies, with cooperation gradually shifting toward late-stage clinical trials and commercial production. On the new client acquisition front, the company is persistently pursuing development with large global pharmaceutical enterprises and high-quality biotech firms.

In recent years, Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. has secured projects from three new top-tier multinational pharmaceutical companies while further strengthening partnerships with other overseas giants. Meanwhile, the number of domestic innovative drug clients has steadily increased, with a growing influx of mid-to-late-stage clinical programs.